An Institute Devoted to Translational Biomedical Research
Home | Contact | Links | 简体中文版
Keywords:
  About Us Research Graduate Education Cooperation and Exchange Translational Research System Technology Platforms Faculty and Staff Join Us  
 
In the news
Introduction of IHS in Immunology
From Immunology to stem cells, searching for new strategies to treat human disease

Introduction of IHS in International Innovation
The world leading research publication
 
Picture News

The 11th IHS International Elite Forum was Held Successfully on May 26th, 2016
 
Research Progress
Targeted AID -mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells.
Ma Y, Zhang J, Yin W, Zhang Z, Song Y, Chang X.
Nat Methods. 2016 Oct 10. doi: 10.1038/nmeth.4027.
Downregulation of CXCL12 in Mesenchymal Stromal Cells by TGFβ Promotes Breast Cancer Metastasis.
Yu PF, Huang Y, Xu CL, Lin LY, Han YY, Sun WH, Hu GH, Rabson AB, Wang Y, Shi YF.
Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.252.
 
Upcoming Seminars
[2017-4-24]
Lab Meeting: ASXL mutations and myeloid malignancies
[2016-12-30]
HEALTH SCIENCES FRONTIERS FORUM: New Insights into the Genetic Basis of Human Complex Traits
 
News and Events
[2017-5-3]
IP3R-mediated Ca2+ signals govern hematopoietic and cardiac divergence of Flk1+ cells via calcineurin-NFATc3-Etv2 pathways
[2017-3-30]
A CD44v+ Subpopulation of Breast Cancer Stem-like Cells with Enhanced Lung Metastasis Capacity
 
Positions
FACULTY POSITIONS
The Institute of Health Sciences (IHS), jointly founded in 1999 by Shanghai Institutes for Biological Sciences (SIBS) of the Chinese Academy of Sciences (CAS) and Shanghai Jiao Tong University School of Medicine (SJTUSM), is devoted to translational biomedical research.
 
Copyright 2002-2016 The Institute of Health Sciences, SIBS, CAS / SJTUSM All Rights Reserved
225 South Chongqing Road, Shanghai, 200025 P.R. China Tel: 86-21-63847798 / 54923254 Fax: 86-21-63852579
Shanghai ICP #05033115